Medtronic stock gains 3.08% as MiniMed exit resets portfolio

Medtronic stock traded at 86.97 euros on Lang & Schwarz at 16:15:46 CET on Friday, October 30, 2026. The quote was 3.08 percent above the 84.37-euro level in the relevant October 27 report, a separate comparison from the Xetra session.

Medtronic's portfolio reset is now complete. The company finished the separation of MiniMed on October 15, 2026, after exchanging its remaining interest in the diabetes technology business for Medtronic ordinary shares.

MiniMed Exit Changes the Portfolio

According to Medtronic, the company exchanged 252,813,348 MiniMed shares for 55,032,401 Medtronic ordinary shares. The exchange offer was 5.4 times subscribed, and Medtronic no longer retains an equity stake in MiniMed.

The transaction gives investors a clearer view of the remaining medical-device group. Management said the company will concentrate its resources on cardiovascular, neuroscience and surgical portfolios. That focus creates a new operating benchmark: future results will show whether the remaining franchises can sustain growth without the diabetes business inside the group.

What Investors Watch Next

The final exchange results released on October 14 show that 297,521,390 Medtronic shares were validly tendered and not withdrawn, while 55,032,401 shares were accepted. The final proration factor for most tendered shares was 18.289133 percent, according to Medtronic's final exchange announcement.

For investors, the separation is a structural change rather than a standalone earnings result. The next assessment will center on execution across the focused portfolio, product adoption and the conversion of development efforts into revenue and profit.

Find the real-time quote of Medtronic plc stock for the latest trading information.

Broader investor sentiment can be assessed through the S&P 500 market environment.

More news and analyses on Medtronic plc stock are available in the company topic.